Literature DB >> 17881890

Evidence based route of administration of vaccines.

I F Cook1.   

Abstract

Vaccination is a proven public health initiative, however it is imperative in the context of increasing concerns about vaccine induced adverse reactions and a decreasing incidence of diseases they prevent that the optimal route for their administration is defined. Traditionally all vaccines were given by subcutaneous injection until it was recognized that adjuvanted vaccines given via this route induced an unacceptable rate of injection site reaction. Evidence-based medicine has been championed as a way of improving the quality of patient care. Application of this methodology to the route of administration of vaccines demonstrates that vaccines should be given by intramuscular injection in preference to subcutaneous injection as the intramuscular route is associated with better immune response and a lower rate of injection site reaction. The basis of this superiority is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881890     DOI: 10.4161/hv.4.1.4747

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  20 in total

1.  Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.

Authors:  Ayesa Syenina; Esther S Gan; Justin Z N Toh; Ruklanthi de Alwis; Lowell Z Lin; Christine Y L Tham; Jia Xin Yee; Yan Shan Leong; Huizhen Sam; Charlene Cheong; Yii Ean Teh; Ian L E Wee; Dorothy H L Ng; Kuan Rong Chan; Jean X Y Sim; Shirin Kalimuddin; Eugenia Z Ong; Jenny G Low; Eng Eong Ooi
Journal:  PLoS Biol       Date:  2022-05-31       Impact factor: 9.593

2.  Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Authors:  Hoai J Ly; Shoko Nishiyama; Nandadeva Lokugamage; Jennifer K Smith; Lihong Zhang; David Perez; Terry L Juelich; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Vaccine       Date:  2017-10-20       Impact factor: 3.641

Review 3.  Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.

Authors:  Michael R Turner; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-01-11       Impact factor: 3.534

4.  Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents.

Authors:  Helen Petousis-Harris; Catherine Jackson; Joanna Stewart; Gregor Coster; Nikki Turner; Felicity Goodyear-Smith; Diana Lennon
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.

Authors:  Eita Sasaki; Haruka Momose; Yuki Hiradate; Keiko Furuhata; Mamiko Takai; Hideki Asanuma; Ken J Ishii; Takuo Mizukami; Isao Hamaguchi
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

Review 6.  Administering Multiple Injectable Vaccines During a Single Visit-Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally.

Authors:  Samantha B Dolan; Manish Patel; Lee M Hampton; Eleanor Burnett; Daniel C Ehlman; Julie Garon; Emily Cloessner; Elizabeth Chmielewski; Terri B Hyde; Carsten Mantel; Aaron S Wallace
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

7.  SnoopLigase peptide-peptide conjugation enables modular vaccine assembly.

Authors:  Anne-Marie C Andersson; Can M Buldun; David J Pattinson; Simon J Draper; Mark Howarth
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

Review 8.  Delivery Routes for COVID-19 Vaccines.

Authors:  Jang Hyun Park; Heung Kyu Lee
Journal:  Vaccines (Basel)       Date:  2021-05-19

9.  Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults.

Authors:  Hiroyuki Kishino; Kenichi Takahashi; Miyuki Sawata; Yoshiyuki Tanaka
Journal:  Hum Vaccin Immunother       Date:  2018-04-12       Impact factor: 3.452

10.  Methods for predicting vaccine immunogenicity and reactogenicity.

Authors:  Patrícia Gonzalez-Dias; Eva K Lee; Sara Sorgi; Diógenes S de Lima; Alysson H Urbanski; Eduardo Lv Silveira; Helder I Nakaya
Journal:  Hum Vaccin Immunother       Date:  2019-12-23       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.